首页> 美国卫生研究院文献>Cancer Research and Treatment : Official Journal of Korean Cancer Association >Prognostic Role and Clinical Association of Tumor-Infiltrating Lymphocyte Programmed Death Ligand-1 Expression with Neutrophil-Lymphocyte Ratio in Locally Advanced Triple-Negative Breast Cancer
【2h】

Prognostic Role and Clinical Association of Tumor-Infiltrating Lymphocyte Programmed Death Ligand-1 Expression with Neutrophil-Lymphocyte Ratio in Locally Advanced Triple-Negative Breast Cancer

机译:局部浸润性三阴性乳腺癌的肿瘤浸润淋巴细胞程序性死亡配体1表达与中性粒细胞-淋巴细胞比率的预后作用和临床关联

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PurposeTumor-infiltrating lymphocyte (TIL), programmed death-ligand 1 (PD-L1) expression and neutrophil-to-lymphocyte ratio (NLR) is associated to immunogenicity and prognosis of breast cancer. We analyzed baseline NLR, changes of NLR, TIL, and PD-L1 during neoadjuvant chemotherapy (NAC) and their clinical implication in triple-negative breast cancer (TNBC).
机译:目的肿瘤浸润淋巴细胞(TIL),程序性死亡配体1(PD-L1)表达和中性白细胞与淋巴细胞之比(NLR)与乳腺癌的免疫原性和预后相关。我们分析了基线NLR,新辅助化疗(NAC)期间NLR,TIL和PD-L1的变化及其在三阴性乳腺癌(TNBC)中的临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号